This resource is designed for use in the evaluation of tuberculosis (TB) contact investigations in congregate settings. It provides explanatory text and tools for assessing health care worker performance and skills as well as programmatic outcomes of contact investigations in congregate settings.
This fact sheet provides an overview of TB diagnosis, treatment, and drug-resistant TB. It also reviews the Medecins Sans Frontieres (MSF), campaign for Access to Essential Medicines, which has dealt with TB since its first day of operations more than 30 years ago.
This report provides standardized recommendations for public health officials, veterinarians, animal venue operators, animal exhibitors, visitors to animal venues and exhibits, and others concerned with disease-control and with minimizing risks associated with animals in public settings. The...
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.